Skip to main content


Dr Furlong’s research team are dedicated to understanding the mechanisms of chemoresistance in breast and ovarian cancer and the development of predictive microRNA biomarkers and drug targets.

Her research focuses on the application of novel next generation sequencing approaches to detect the post transcriptional chemical modification of microRNAs.

The objective of this research is the development of clinically actionable biomarker panels for biosensor development and new drug targets for chemoresistant cancer. 

Find out more


Open to PhD applications in the field of cancer research, chemoresistance and DNA damage, cell and molecular biology, transcriptomics, biomarker development and drug discovery.

Make a PhD enquiry

Research students

PhD Title: Experimental Therapeutic and Pharmacogenomics

Name: Miss Sama’ Abderahman
Years of Study: 2016-2019
Country: Jordan

PhD Title: Understanding the conformational dynamics of the genetic variants of the human FKBPL

Name: Aaron Maquire
Years of Study: 2016-2019
Country: Northern Ireland


Alumni: where are they now?

Dr Karolina Weiner-Gorzel

PhD Title: The contribution of the microRNA miR-433 to the pathology of ovarian cancer

Years of Study: 2010 - 2014
Country: Ireland
Current position: 3rd year Graduate entry medicine Student at University College Cork, Ireland.

Dr Tara Byrne

PhD Title: The evaluation of the effects of the mitotic arrest deficiency protein 2 (MAD2) and the miR-433 microRNA on chemoresistance and cancer prognosis.

Years of Study: 2013 - 2017
Country: Northern Ireland
Current position: Team Leader, Randox

Research at Queen's

Postgraduate research

Start your application

Apply now
graduate school interior

Postgraduate Experience

The Graduate School

Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.

The gateway to your postgraduate experience